Information  X 
Enter a valid email address

DeepMatter Group PLC (DMTR)

  Print   

Wednesday 25 May, 2022

DeepMatter Group PLC

Issue of Equity and TVR

RNS Number : 8077M
DeepMatter Group PLC
25 May 2022
 

 


 

25 May 2022

 

Issue of Shares and Total Voting Rights

 

DeepMatter Group Plc (AIM: DMTR, "Deepmatter", the "Group"), the digital chemistry data and software company, announces as a result of the subscription to Ordinary Shares in the Company by Alan Aubrey, incoming Chair, application has been made for 200,000,000 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on or around 31 May 2022.

 

Following the subscription, Alan Aubrey will be interested in 207,311,393 Ordinary Shares which represents 5.17 per cent. of the issued share capital as enlarged by the subscription. The subscription price was 0.1 pence per Ordinary Share.

 

The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following Admission, the Company's issued share capital will consist of 4,009,897,281 Ordinary Shares. Accordingly, the figure of 4,009,897,281 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

For more information contact

 

DeepMatter Group Plc                                                                                                                 0141 548 8156
Fraser Benson, Chief Financial Officer                                  
                                             


Canaccord Genuity Limited (Nominated Advisor and Broker)
                                            020 7523 8000
Bobbie Hilliam


Meare Consulting
  07990 858548
Adrian Duffield

   

About DeepMatter Group plc 

 

DeepMatter 's SmartChemistry™ platform enables scientists across a range of industries, including pharma, biotech, agri-science, scientific publishers and contract research organisations (CROs), toeasily capture, access and exploit the vast amounts of data created in chemical reactions. 

 

DeepMatter integrates its proprietary chemistry data and proprietary software to significantly improve productivity, efficiency, discovery, safety and sustainability of chemical reactions for its customers.

 

DeepMatter's SmartChemistry™ platform capitalises on the combination of its cloud technology, low cost-sensors, connectivity to laboratory hardware and high-performance computing trends such as artificial intelligence (AI).

 

Visit: www.deepmatter.io and follow @deepmattergroup

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOESELFDIEESEFI

a d v e r t i s e m e n t